[Resistance screening].
Sierra
Saleta
S
Institut für Virologie, Universität zu Köln.
Lengauer
Thomas
T
Kaiser
Rolf
R
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004252:DNA Mutational Analysis; D004305:Dose-Response Relationship, Drug; D024921:Drug Resistance, Multiple, Viral; D004359:Drug Therapy, Combination; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D055118:Medication Adherence; D008826:Microbial Sensitivity Tests; D019562:Viral Load
D019380:Anti-HIV Agents